Inventor
MITCHAM JENNIFER
US22 patents
⚠️ This page may combine multiple inventors who share the name “MITCHAM JENNIFER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THERACLONE SCIENCES INC
12 patentsUS10087239B2Oct 2, 2018
Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody
THERACLONE SCIENCES INC14 citations91
US9464131B2Oct 11, 2016
Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody
THERACLONE SCIENCES INC18 citations91
US11319362B2May 3, 2022
Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies
THERACLONE SCIENCES INC3 citations83
US10865234B2Dec 15, 2020
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC1 citations72
US10836811B2Nov 17, 2020
Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody
THERACLONE SCIENCES INC1 citations72
US10407493B2Sep 10, 2019
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC1 citations72
US12312396B2May 27, 2025
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC0 citations62
US12018067B2Jun 25, 2024
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC0 citations62
US11584789B2Feb 21, 2023
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC0 citations62
US11845789B2Dec 19, 2023
Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies
THERACLONE SCIENCES INC0 citations61
US10239934B2Mar 26, 2019
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC0 citations51
US9920111B2Mar 20, 2018
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC0 citations51
GRANDEA III ANDRES
3 patentsUS8057796B2Nov 15, 2011
Compositions and methods for the therapy and diagnosis of influenza
GRANDEA III ANDRES14 citations90
US8460671B2Jun 11, 2013
Compositions and methods for the therapy and diagnosis of influenza
GRANDEA III ANDRES5 citations82
US8114402B2Feb 14, 2012
Compositions and methods for the therapy and diagnosis of influenza
GRANDEA III ANDRES6 citations82
GRANDEA III ANDRES G
3 patentsUS8916160B2Dec 23, 2014
Compositions and methods for the therapy and diagnosis of influenza
GRANDEA III ANDRES G11 citations80
US8974788B2Mar 10, 2015
Compositions and methods for the therapy and diagnosis of influenza
GRANDEA III ANDRES G4 citations69
US8858948B2Oct 14, 2014
Compositions and methods for the therapy and diagnosis of influenza
GRANDEA III ANDRES G1 citations48